2024 AABB Annual Meeting

Abstract
Preparationand Submission
Guidelines
This document will provide the information you need to prepare your abstract
for submission to the 2024 AABB Annual Meeting.

CONTENTS
Abstract Categories and Topics

2

Abstract Timeline

3

Author(s) Responsibilities

3

How to Submit Your Abstract

4

Abstract Selection and Notification

6

Categories and Keywords
You will be asked to choose a primary category and up to five keywords. The primarycategory should reflect the overall topic of your abstract. Keywords should reflect other topics
that are covered in your abstract submission.
Biotherapies, CellularTherapies, andImmunotherapies
Collections, Processing and Storage
Cord blood (including cord tissue andperinatal cells)
Hematopoietic Cell Therapy/Transplant Immunotherapies(includes CAR T cells)
Nonhematopoietic Cell Therapy
Process Improvement
Product Development andManufacturing
Quality Control/Quality Assurance
Regenerative Medicine
Regulations
Somatic Cell Therapy

Education/Developing
Curriculum
Competency Assessment Methods
Curriculum Development,
Implementation and Evaluation
Professional Development
Training Methods for Employees,
Students, Residents and Fellows

Immunohematology andGenetic Testing (red cells,
leukocytes and platelets)

Immunohematology (includes serology)
Molecular Diagnostics and Testing

Hematology and Coagulation
Disorders
Testing and Assay Development

Blood Center/Hospital-Based
Donor Center

Information Technology
and Informatics

Blood Center/Donor Center Inventory
ManagementCollections and Product Manufacturing
Component Processing
Donor Apheresis
Donor Collections
Donor Hemovigilance
Donor Recruitment and Retention
Donor Testing

Data Management and Analytics
Electronic Health/Medical Records
Laboratory Information Systems

Cell Biology, Immunology
and Biochemistry(Basic and Preclinical Research)
Leukocytes (includes Experimental
transplantation/immunotherapy)
Platelets
Red Cells

InstrumentationInventories
Inventory Distribution
Inventory Management
Inventory Storage

LeadershipMarketingOperations
Strategic Planning

Patient Blood Management
Public Health, Policyand Ethics
Quality
Laboratory Safety
Proficiency Testing
Quality Assurance
Quality Control
Quality Management Systems
Standards, Regulations and Accreditation

Therapeutic Apheresis
Tissue Banking andManagement
Transfusion Service
Evidence Based Medical Practices
Patient Safety
Patient Testing
Pediatric Transfusion Clinical Medicine
Perioperative and Anesthesia
Recipient/Patient Hemovigilance –Noninfectious Adverse Events(Transfusion Reactions)
Recipient/Patient Hemovigilance –Transfusion Transmitted
Infectious Diseases
Transfusion Practices
Trauma and Massive Transfusion
Practices
Transfusion Service Inventory
Management, Storage, andDistributions

Management
Financial Management
Laboratory Administration
Personnel Management
Practice Management
Quality Management| 2024 AABB Annual Meeting Abstract Preparation and Submission Guidelines2

2024 Abstract Timeline
May 15End of July

October 19-22

Notificationof Acceptance*

2024

HOUSTON

Submission
Site Closes* Abstract submitter will receive notification of the status of their abstract via email.

OCTOBER 19-22

AABB Annual
Meeting,Houston, Texas

Author(s) Responsibilities
Submission of an abstract indicates the following:
1 The author(s) has not published the data in a scientific journal; nor, has the data been accepted for publication
before the AABB abstract submission closing date.
2 The author(s) has not presented the data at another national or international annual scientific meeting.
3 The accuracy of the submitted abstract is the responsibility of the author(s). Errors made on your submitted abstract
will appear in publication.
4 Submission of an abstract constitutes a commitment by the author(s) to present it if accepted. Failure to present, if notjustified, may jeopardize future acceptance of abstracts. Expenses associated with the submission and presentationof an abstract are the responsibility of the author/presenter. The presenter is required to attend the annual meeting
during the day of presentation and must submit the applicable registration fee. If your abstract is selected for oralpresentation, the presenting author will receive a complimentary registration for the day of the presentation.
5 The content of the presentation and reference materials must remain the responsibility of the author(s). A
commercial supporter may help prepare the presentation, but they should not be biased to advance the proprietaryinterest of the sponsor.

| 2024 AABB Annual Meeting Abstract Preparation and Submission Guidelines3How to Submit Your Abstract
All abstracts should be as informative as possible and follow the guidelines below.
(Abstracts that do not follow all format guidelines will be rejected.)

1. Format
Abstracts must include the following sections: Background/Case Studies – information regarding the objectives/goals or why the study was performed.
 Study Design/Methods – information about the key methods utilized in the study.
 Results/Findings – summary of the results observed.
 Conclusion – a statement of the author(s)’ conclusion supported by the stated results.

NOTE: Quantitative data must be included in scientific abstracts. Although data should be summarized,abstracts must include specific reference to numbers studied and statistical significance of findings. It is
insufficient to state: “The results will be discussed” or “The data will be presented.” A table or graph may
be helpful in presenting data.

2. Table or Figure A maximum of one table or figure is accepted for each abstract.
 Naming convention for table and figure – please include the same title when you reference the figure
or table in your abstract text.
• Please use:
• Table 1• Figure A There are two preferred formats for digital artwork submission: JPEG or PNG.
 Tables and figures can be submitted in black and white or color.

| 2024 AABB Annual Meeting Abstract Preparation and Submission Guidelines43. Additional Submission Requirements
Every effort will be made to publish the abstract exactly as submitted. Although abstracts will be typeset forelectronic distribution, they will not be edited or corrected by the AABB staff except as needed to conformto publication style. Please ensure that your submission adheres to the following guidelines:
NEW: Low- and Middle-Income Countries (LMIC) Verification
Please indicate if your research was conducted in an LMIC according to World Bank classifications.

 Summary of Importance to the Field
Submitting authors will be asked to provide a brief summary (a few sentences, maximum 500 characters) about
why the abstract is novel or important to the field. Although previously published work will not be accepted, asnoted in the Author(s) Responsibilities, submission of follow-up studies or reexamination of data are encouraged.
In these instances, it is particularly important that the author articulates what is new or different about theresearch in this abstract.
 Commercial Bias
• If the presentation involves commercial products, it must be objective and rely on scientific methods.
• Presentations must be free of commercial bias for or against any product.
• Generic names should be used whenever possible. Abstracts submitted for promotional purposes will be rejected.
 The combined length of the abstract body and title may not exceed 2,900 characters including spaces.
Table/figure and Summary of Importance to the Field will NOT count toward the total character count. Abstracts
that exceed this character limit will be rejected by the online submission site and must be modified before theabstract can be submitted.
 Titles should be indicative of the content of the abstract. The title should be brief and must be entered in title case(first letter of every word capitalized).
 Author(s) names should have no titles or degrees listed. Author(s) institutions should be listed as precisely as
possible (include city, state or country).
 Author(s) should include statistics, when it would permit a clearer interpretation of the data.
 All units of measure must be expressed in the metric system; temperatures in Celsius.
 Generic names of drugs must be given, typed in lower case. If the proprietary name is given, the first letter
must be capitalized.
 Unless an abbreviation is widely known and accepted (Fya, CPD, HIV ), the term or phrase must be written in full
the first time it appears in the abstract, followed immediately by the abbreviation in parentheses, i.e. hydroxyethyl
starch (HES) or filtration leukapheresis (FL). Do not use abbreviations in the title.
 Avoid starting sentences with Arabic numbers.

| 2024 AABB Annual Meeting Abstract Preparation and Submission Guidelines5 Any human subjects/animal research presented must have been approved by the appropriate agencies and havebeen in accordance with applicable ethical standards.
 Except in rare cases, no more than ten (10) authors may be submitted and listed with each abstract. As per the rule inmedical research publication, each of the authors must have contributed in at least one of three ways: 1) substantial
participation in the research being reported, 2) writing of the submission, or 3) review/editing of the abstracts.
 Author(s) are strongly encouraged to save an electronic or printed copy of their abstract for their records before submitting.
 Avoid use of the first person in descriptions of the authors’ previous work.
Unacceptable: “We previously demonstrated that…”
Acceptable: “It has been shown…” or “Investigators previously demonstrated that…”

Abstract Selection and Notification
1. Acceptance Criteria
Abstracts will be reviewed based on: Originality, novelty to the field Clear expression of concepts and data
 Sufficient data Apparent valid conclusions supported by data provided
 Interest/relevance for the AABB annual meeting

2. Rejection Criteria
Abstracts will be rejected by peer reviewers for any of the following reasons:A) Insufficient data presentedB) Statistical analysis needed, but not providedC) Stated conclusion cannot be reached from data presentedD) Information previously published or generally well known and documentedE) Format instructions not followed – no conclusion given, etc.
F) Information has limited significance or relevance and interest for national AABB meeting| 2024 AABB Annual Meeting Abstract Preparation and Submission Guidelines6G) Abstract poorly written, confusing or not clear, or contains major spelling or syntax errors
H) Commercial bias/advertisingI)

Error in method or data presented

J)

Other serious flaws, in the judgment of the peer reviewers

3. Decision Notification
Abstract decision notifications will be made to the abstract submitter by email.

If accepted, abstracts must be presented at the AABB Annual Meeting. The presenting author must register forthe meeting, prepare their poster (or oral presentation if selected) and present during their assigned session
time. Failure to do so, without adequate notification and justification, may prevent the authors from submitting
abstracts to future meetings. All posters must be mounted throughout the duration of the designated time andmay not be removed early for any reason.

| 2024 AABB Annual Meeting Abstract Preparation and Submission Guidelines

7